A Phase II randomised, double-blind, placebo-controlled trial of S-Adenosyl Methionine in participants with mild cognitive impairment or dementia due to Alzheimer’s disease
- Yassi, Nawaf (Chief Investigator)
- Watson, Rosie (Investigator 02)
- Ford, Andrew (Investigator 03)